Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BC12011a

Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases/63 cores, replacing BC12011
Unstained: $115.00 Add to Cart
H&E (BC12011as*): $115.00 Add to Cart

Microarray Panel:Bladder transitional cell carcinoma tissue microarray, containing 60 cases of bladder transitional cell carcinoma, plus 3 adjacent normal bladder tissue, single core per case
Cores:63
Cases:63
Layout:9 cols × 7 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789 
A Bla Bla Bla Bla Bla Bla Bla Bla Bla  
B Bla Bla Bla Bla Bla Bla Bla Bla Bla  
C Bla Bla Bla Bla Bla Bla Bla Bla Bla  
D Bla Bla Bla Bla Bla Bla Bla Bla Bla  
E Bla Bla Bla Bla Bla Bla Bla Bla Bla  
F Bla Bla Bla Bla Bla Bla Bla Bla Bla  
G Bla Bla Bla Bla Bla Bla Bla Bla Bla Marked point
Legend: Bla - Bladder

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IV), - NAT, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 80 Bladder Transitional cell carcinoma 1 II T2N0M0 Malignant
A2 2 M 56 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
A3 3 M 45 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
A4 4 M 63 Bladder Transitional cell carcinoma 1 II T2aN0M0 Malignant
A5 5 M 70 Bladder Transitional cell carcinoma 1 II T2bN0M0 Malignant
A6 6 M 35 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
A7 7 M 66 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
A8 8 M 57 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
A9 9 F 45 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B1 10 M 70 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
B2 11 M 56 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B3 12 M 43 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B4 13 F 37 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B5 14 M 71 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
B6 15 M 65 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B7 16 M 78 Bladder Transitional cell carcinoma 2 II T2bN0M0 Malignant
B8 17 M 66 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
B9 18 M 60 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
C1 19 M 72 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
C2 20 F 79 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
C3 21 M 42 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
C4 22 M 61 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
C5 23 F 54 Bladder Transitional cell carcinoma 2 IV T3N0M1 Malignant
C6 24 M 67 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
C7 25 F 54 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
C8 26 M 72 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
C9 27 M 37 Bladder Transitional cell carcinoma (sparse) – I T1N0M0 Malignant
D1 28 F 72 Bladder Transitional cell carcinoma 1 II T3N0M0 Malignant
D2 29 F 49 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
D3 30 F 76 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
D4 31 F 61 Bladder Transitional cell carcinoma 1 II T3N0M0 Malignant
D5 32 M 69 Bladder Transitional cell carcinoma 1 I T1N0M0 Malignant
D6 33 M 71 Bladder Transitional cell carcinoma 1 II T2bN0M0 Malignant
D7 34 M 68 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
D8 35 M 78 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
D9 36 F 52 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
E1 37 F 58 Bladder Transitional cell carcinoma 2 II T2bN0M0 Malignant
E2 38 M 51 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
E3 39 M 71 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
E4 40 M 64 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
E5 41 M 50 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
E6 42 M 50 Bladder Transitional cell carcinoma (sparse) – I T1N0M0 Malignant
E7 43 F 64 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
E8 44 M 65 Bladder Transitional cell carcinoma 2 II T2bN0M0 Malignant
E9 45 M 38 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
F1 46 M 58 Bladder Transitional cell carcinoma 2 II T2aN0M0 Malignant
F2 47 M 57 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
F3 48 M 71 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
F4 49 F 47 Bladder Transitional cell carcinoma 3 II T2bN0M0 Malignant
F5 50 M 65 Bladder Transitional cell carcinoma 3 II T2aN0M0 Malignant
F6 51 M 60 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
F7 52 M 67 Bladder Transitional cell carcinoma 3 III T3aN0M0 Malignant
F8 53 M 57 Bladder Transitional cell carcinoma 3 II T2N0M0 Malignant
F9 54 M 78 Bladder Transitional cell carcinoma 3 II T2aN0M0 Malignant
G1 55 M 70 Bladder Transitional cell carcinoma 3 II T2bN0M0 Malignant
G2 56 F 48 Bladder Transitional cell carcinoma 3 II T2bN0M0 Malignant
G3 57 M 70 Bladder Transitional cell carcinoma 3 II T2N0M0 Malignant
G4 58 M 45 Bladder Transitional cell carcinoma 3 III T3bN0M0 Malignant
G5 59 M 74 Bladder Transitional cell carcinoma 3 II T2bN0M0 Malignant
G6 60 M 58 Bladder Transitional cell carcinoma 3 II T2N0M0 Malignant
G7 61 F 37 Bladder Cancer adjacent normal bladder tissue – – – NAT
G8 62 F 50 Bladder Cancer adjacent normal bladder tissue – – – NAT
G9 63 M 35 Bladder Normal bladder tissue – – – Normal
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal